Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 1100
  • Start Date: October 2021
Restarting Anticoagulation After Traumatic Intracranial Hemorrhage (Restart tICrH): a Prospective Randomized Open Label Blinded Endpoint (PROBE) Pragmatic Time-dose, Response Adaptive Clinical Trial
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 200
  • Start Date: June 1, 2021
International Registry on the Diagnosis and Treatment of Inferior Vena Cava Thrombosis
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Drug
  • Participants: 172
  • Start Date: June 1, 2021
Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Drug
  • Participants: 12
  • Start Date: February 2, 2021
Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 1000
  • Start Date: February 2021
A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 330
  • Start Date: February 2021
Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug, Device, Diagnostic Test
  • Participants: 150
  • Start Date: January 18, 2021
Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test in Patients at Extremely High Risk of Postoperative Venous Thromboembolism.
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 2700
  • Start Date: January 2021
Statins for Venous Event Reduction in Patients With Venous Thromboembolism
Clinical Trial
  • Status: Recruiting
  • Participants: 80
  • Start Date: December 22, 2020
FUVID Study: A Multi-center, Prospective Study Evaluating Exercise Intolerance and Dyspnea on Exertion in Patients Following First-episode Deep Venous Thrombosis and Pulmonary Embolism
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 1455
  • Start Date: December 20, 2020
Sulodexide (VESSEL®) for the Prevention of Recurrent Venous Thromboembolism in Elderly Patients After a First Episode of Venous Thrombembolism
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 44
  • Start Date: December 8, 2020
Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis: A Pilot Study to Evaluate if Hydroxyethylrutoside Reduces the Risk of Post-Thrombotic Syndrome in Patients With DVT.
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 30
  • Start Date: December 4, 2020
A Prospective Trial to Determine if it is Safe to Use the gekoTM Neuromuscular Electrostimulation Device in a Pacemaker Population.
Showing 1-12 of 139